塩野義薬：Shionogi Announces FDA Approval of XOFLUZATM (Baloxavir Marboxil)- for the Treatment of Acute, Uncomplicated Influenza - - 有報キャッチャー

塩野義薬（4507）　Shionogi Announces FDA Approval of XOFLUZATM (Baloxavir Marboxil)- for the Treatment of Acute, Uncomplicated Influenza - 2018/10/25

/-

読み込み中…